Pansulpha Oral Solution
بانسولفا محلول فموي
Pansulpha Oral Solution contains Sulphaquinoxaline sodium 250 mg/ml (eq. to 232.9 mg sulphaquinoxaline base) for treatment of coccidiosis, fowl cholera, and fowl typhoid in broiler chickens, turkeys, and calves.
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Broiler | 1 – 1.7 ml / liter of drinking water | oral | Intermittent schedule (2-3 days on, 3 off, 2 on) |
| Turkey | 1 – 1.7 ml / liter of drinking water | oral | Intermittent schedule (2 on, 3 off, 2 on, 3 off, 2 on) |
| Cattle | 0.6 ml / 25 kg body weight | oral | 3 – 5 days |
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| Broiler | 10 | ||
| Turkey | 10 | ||
| Cattle | 10 |
Indications
-
Broiler chickens and turkeys: Treatment of Coccidiosis in broiler chickens caused by Eimeria tenella, E. necatrix, E. acervulina, E. maxima, and E. brunetti. Treatment of Coccidiosis in turkeys caused by Eimeria meleagrimitis and E. adenoeides. Treatment of acute fowl cholera caused by Pasteurella multocida in broiler chickens and turkeys. Treatment of fowl typhoid caused by Salmonella gallinarum in broiler chickens and turkeys. Calves: Treatment of Coccidiosis caused by Eimeria bovis and E. zurnii in calves.
Contraindications
-
Not used in layers.
-
Not used in animals with functional rumen.
-
Not used in dairy animals.
-
Sulfonamides hypersensitivity.
-
Severe hepatic impairment.
Precautions
No precautions information available.
Side Effects
-
Haemolytic anaemia.
-
Agranulocytosis.
-
Crystalluria.
Images
Documents
-
Download
Official Pharma Swede Product Specification
Datasheet
Active Ingredients
-
Sulphaquinoxaline
233 mg/ml
Diseases
Related Products
Related Products By Active Ingredient
Companies
-
Pharma Swede Egypt
Manufacturer
Alternatives
No alternatives available.